FRANCISCO
PURROY GARCIA
CON
Mutua de Terrassa
Terrassa, EspañaPublicaciones en colaboración con investigadores/as de Mutua de Terrassa (20)
2023
-
Association of Time of Day with Outcomes among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia
Stroke, Vol. 54, Núm. 3, pp. 770-780
-
Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population
International Journal of Stroke, Vol. 18, Núm. 2, pp. 229-236
-
Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study
Neurologia, Vol. 38, Núm. 6, pp. 412-418
-
Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia
European Stroke Journal, Vol. 8, Núm. 2, pp. 557-565
2022
-
Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020
Stroke, Vol. 53, Núm. 11, pp. 3289-3294
-
The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm
Journal of Stroke and Cerebrovascular Diseases, Vol. 31, Núm. 1
-
Workflow Times and Outcomes in Patients Triaged for a Suspected Severe Stroke
Annals of Neurology, Vol. 92, Núm. 6, pp. 931-942
2021
-
Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia
Cerebrovascular Diseases, Vol. 50, Núm. 5
-
Effectiveness of thrombectomy in stroke according to baseline prognostic factors: Inverse probability of treatment weighting analysis of a populationbased registry
Journal of Stroke, Vol. 23, Núm. 3, pp. 401-410
-
Impact of COVID-19 infection on the outcome of patients with ischemic stroke
Stroke, Vol. 52, Núm. 12, pp. 3908-3917
2020
-
Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain
Scientific Reports, Vol. 10, Núm. 1
-
Vascular Occlusion Evolution in Endovascular Reperfusion Candidates Transferred from Primary to Comprehensive Stroke Centers
Cerebrovascular Diseases, Vol. 49, Núm. 5, pp. 550-555
2019
-
Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients
Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 151-164
2017
-
GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke
Stroke, Vol. 48, Núm. 5, pp. 1147-1153
-
Influence of Hospital Type on Outcomes of Individuals Aged 80 and Older with Stroke Treated Using Intravenous Thrombolysis
Journal of the American Geriatrics Society, Vol. 65, Núm. 9, pp. E117-E122
2016
-
Aplicabilidad del índice SPAN-100 en una cohorte prospectiva y contemporánea de pacientes tratados con rtPA por vía intravenosa en Cataluña
Neurologia, Vol. 31, Núm. 9, pp. 592-598
2014
-
Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study
Cerebrovascular Diseases, Vol. 38, Núm. 5, pp. 328-336
-
Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy
Stroke, Vol. 45, Núm. 4, pp. 1046-1052
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218
2009
-
Prevalencia de enfermedad arterial periférica asintomática en pacientes con ictus isquémico no cardioembólico
Neurologia, Vol. 24, Núm. 6, pp. 366-372